Proteros is a biotech company focused on enabling lead discovery for challenging targets. Proteros has established a profitable discovery service business with a best-in-class enabling technology platform for structure accelerated lead discovery. Their track record is proven by an outstanding project success rate. Proteros’ proprietary pipelineincludes highly disease relevant target classes such as kinases, epigenetic targets and GPCRs. Their success is built on unique know how and expertise in understanding the role of protein structures involved in protein and small molecule interactions that are responsible for the pathogenesis of many diseases.

Biotechnology

Proteros

Torsten Neuefeind

Steven L. Holshouser

George Buckley

Dr. Tanja Vukicevic

Peter Persigehl

The Research and Development Team at Proteros is dedicated to advancing lead discovery through innovative protein structure analysis and biophysical methodologies. Comprised of experts in protein crystallography, biophysics, and protein sciences, the team collaborates to develop high-throughput assays, optimize screening processes, and elucidate protein-ligand interactions. Their efforts are crucial in identifying promising candidates for therapeutic interventions against challenging disease targets, ultimately contributing to Proteros' robust discovery pipeline.

Research and Development Team

About

Team members

Other teams at Proteros

Leadership Team